Introduction: The antiplatelet effects of low-dose aspirin (LDA) vary between individuals.
Here, we investigated the relationship between the incidence of LDA-induced mucosal …

Background: Patients taking low-dose aspirin have a higher incidence of gastroduodenal
ulcers and higher risk of upper gastrointestinal bleeding than patients who do not …

Low-dose aspirin (LDA) is now broadly administered for the prevention of cardiovascular
and cerebrovascular diseases. However, aspirin, even at a low dose, induces adverse …

The use of low-dose aspirin (LDA) is well known to be associated with an increased risk of
serious upper gastrointestinal complications, such as peptic ulceration and bleeding. Until …

Introduction Antithrombotic drugs, such as low-dose aspirin (LDA) and clopidogrel, can
cause upper gastrointestinal complications. Aim The goal of the present study was to …

Abstract Background and Aim: Aspirin enjoys widespread use as an antithrombotic drug, but
such ubiquity also increases the risk of gastrointestinal mucosal injury. Recent studies have …

Background: In esophagus whether antiplatelet drugs, such as low-dose aspirin (LDA) and
clopidogrel, induce mucosal injury by pH changes or by acid reflux is unclear. We designed …

Low-dose aspirin (LDA) is clinically used for the prevention of cardiovascular and
cerebrovascular events with the advent of an aging society. On the other hand, a very low …

Background & Aims: The safety of low-dose daily aspirin therapy in the gastrointestinal tract
is uncertain. Our objectives were to evaluate the long-term effects of very low daily aspirin …

The use of low-dose aspirin (LDA) has been a common preventive measure to reduce the
risk of cardiovascular events. This is attributed to aspirin's ability to inhibit platelet activation …